Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 0.02x is 100% above its 5-year average of -4.12x, around the middle of its 5-year range (-72.73x–63.63x).
98.85% below its 12-month average of 1.74x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 11.89x.
INTEREST COVERAGE RATIO
0.02x
INTEREST COVERAGE RATIO AVG TTM
1.74x
INTEREST COVERAGE RATIO AVG 3Y
0.41x
INTEREST COVERAGE RATIO AVG 5Y
-4.12x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-98.85%
CURRENT VS 3Y AVG
-95.07%
CURRENT VS 5Y AVG
+100.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.07x
median of 333 covered companies
CURRENT VS SECTOR MEDIAN
+100.49%
vs the sector median at left
Eton Pharmaceuticals, Inc.
Market Cap
$1.53B
Interest Coverage Ratio
0.02x
TTM Avg
1.74x
3Y Avg
0.41x
5Y Avg
-4.12x
Market Cap
$1.53B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.52B
Interest Coverage Ratio
-131.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.54B
Interest Coverage Ratio
9.81x
TTM Avg
8.66x
3Y Avg
9.09x
5Y Avg
12.26x
Market Cap
$1.56B
Interest Coverage Ratio
1.06x
TTM Avg
1.06x
3Y Avg
1.45x
5Y Avg
1.23x
Market Cap
$1.47B
Interest Coverage Ratio
30.72x
TTM Avg
19.49x
3Y Avg
15.15x
5Y Avg
21.38x
Market Cap
$1.46B
Interest Coverage Ratio
0.60x
TTM Avg
0.60x
3Y Avg
0.60x
5Y Avg
0.60x
Market Cap
$1.44B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.42B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | $1.53B | 0.02x | 1.74x | 0.41x | -4.12x |
| Braveheart Bio, Inc. (BRVE)vs › | $1.53B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.52B | -131.05x | N/A | N/A | N/A |
| Innoviva, Inc. (INVA)vs › | $1.54B | 9.81x | 8.66x | 9.09x | 12.26x |
| Certara, Inc. (CERT)vs › | $1.56B | 1.06x | 1.06x | 1.45x | 1.23x |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | 30.72x | 19.49x | 15.15x | 21.38x |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 0.60x | 0.60x | 0.60x | 0.60x |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.44B | N/A | N/A | N/A | N/A |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.42B | N/A | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.66B | -3.88x | 0.61x | 0.61x | 0.61x |
Interest Coverage
0.0x
Debt/Equity
0.62
Current Ratio
1.52
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 11.89x |
| 2026-03-31 | -2.87x |
| 2025-12-31 | 2.04x |
| 2025-09-30 | -1.12x |
| 2025-06-30 | -1.23x |
| 2025-03-31 | -0.40x |
| 2024-12-31 | 0.47x |
| 2024-09-30 | 63.63x |
| 2024-06-30 | -56.44x |
| 2024-03-31 | -72.73x |
| 2023-12-31 | -5.52x |
| 2023-09-30 | -17.68x |
| 2023-06-30 | 31.31x |
| 2023-03-31 | -20.11x |
| 2022-12-31 | 4.15x |
| 2022-09-30 | -19.30x |
| 2022-06-30 | -6.15x |
| 2022-03-31 | -20.93x |
| 2021-12-31 | 4.78x |
| 2021-09-30 | -23.67x |
| 2021-06-30 | -9.81x |
| 2021-03-31 | 21.71x |
| 2020-12-31 | -27.58x |
| 2020-09-30 | -27.03x |
| 2020-06-30 | -23.64x |
| 2020-03-31 | -52.86x |
| 2019-12-31 | -66.40x |
